What was the plan?
The School of Pharmacy at Chatham, part of the University of Kent, had the idea to carry a drug inside cancerous cells and kill them from within. Kent Cancer Trust was approached to fund a project to see whether this idea was capable of success.
A project plan was developed that used oligonucleotide delivery systems. but it did not provie possible to confirm that this approach would be commercially viable.
A PhD candidate was found to work on the idea and Kent Cancer Trust paid her salary, tuition fees and bench costs. In addition it was necessary to seek patent advice on the project, since at an early stage excellent progress was achieved. Overall the cost of the project was £73,764.